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ABSTRACT 
Background/Objective:  Chronic subdural hematoma (CSH) is a type of intracranial hemorrhage is commonly 
seen in old age. It has a poor prognosis when misdiagnosed or a delayed treatment can lead to significant 
morbidity. We evaluated the effectiveness of available surgical treatments for the management and outcome of 
CSH. 
Method:  The prospective cases (n = 48) of CSH were included from Department of Neurosurgery, Sheikh Zayed 
Hospital, Lahore during January 2014- December 2017. Detailed history of patients was taken along with 
comprehensive examinations with CT scans and MRIs. The CSH patients were treated surgically either with burr-
hole evacuation (unilateral/bilateral) with irrigation or burr-hole drainage with drain 48 to 72 hours. 
Results:  The mean age of male patients was 68 years and 56 years in female patients. Most of our patients 
recovered (81.25%; GOS 5) uneventfully. Patients were mostly treated with burr-hole evacuation with irrigation. 
The 15% patients had required ICU management with GOS 2-3. Older (> 65 years) male patients were at higher 
risk of CSH. Trauma was not the only major cause of the CSH as history of trauma was not present in the 
majority (< 25%) of the patients. We found following significant risk factors, i.e., hypertension (73%), DM 
(62.5%) and ischemic heart disease (60%) and intake of anticoagulant/antiplatelet drugs (60%). A 4% recurrence 
was reported in our CSH patients. Stroke as a postoperative complication was reported in two patients (4%) and 
only one patient (2%) died of aspiration pneumonia. 
Conclusion:  Chronic subdural hematoma can be effectively treated by simple surgical intervention if diagnosed 
early and mortality can be reduced. We found burr-hole evacuation (unilateral/bilateral) with irrigation an 
effective treatment against CSH, as most of our patients (> 80%) were recovered with it. The trauma was not the 
only cause of CSH as history of trauma was not present in the majority of the patients, therefore, some other 
factors are also involved in the CSH formation in old age. 
Keywords:  Chronic Subdural Hematoma; Bilateral Burr-Hole Evacuation; Trauma; Intracranial Hemorrhage. 
 
INTRODUCTION 
Chronic subdural hematoma (CSH) is frequent type of 
an intracranial hemorrhage commonly seen in old age 
along with different comorbidities.
1-3
 This study was 
aimed to diagnose CSH in patients and evaluate effe-
ctiveness of the treatments followed. We conducted 
this study to evaluate the effectiveness of available 
surgical treatments for the management and outcome 
of CSH at the Department of Neurosurgery at Sheikh 
Zayed Hospital Lahore from January 2014 to 
December 2017. We identified few risk factors of 
chronic subdural hematoma in elderly patients. Glo-
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bally, the incidence of subdural hematoma is increa-
sing since 1967. The prevalence of CSHs is elevating 
now and it is anticipated that it will become the most 
typical neurological condition by the year 2030 in 
United States.
4-5
 Elder patients who are being treated 
with drainage intervention, 32% of one year mortality 
rate is anticipated.
6
 Chronic subdural hematoma can 
develop into its acute form which can result in an 
adverse outcome and survival time.
6-10
 The conditions 
can worsen in these cases and can surpass primary 
brain tumors and metastasis.
11
 Chronic subdural hema-
toma (CSH) has a poor prognosis in case of misdia-
gnosis and/or with a delayed treatment which can lead 
to significant morbidity and mortality. It consists of 
liquefied blood and its breakdown products enclosed 
in a neo-membrane. Chronic subdural hematoma is 
located in the potential space between arachnoid and 
dura-mater. Although, some types of chronic subdural 
hematomas involve days to weeks with a history of 
trauma. However, in the majority of patients there is 
no definite history of trauma which precedes the 
discovery of chronic subdural hematoma. When there 
is no associated trauma, other etiologies should have to 
be considered for example, coagulopathies, vascular 
malformations, neoplastic and inflammatory condi-
tions etc.
5
 A chronic subdural hematoma may result in 
brain compression and subsequent neurological defi-
cits. It is one of the common neurological condition 
and often treated with relatively simple and effective 
surgical procedures. The prognosis for the patients 
CSH is usually misleading. It is estimated that about 
20% of CSH patients can present a poor neurological 
outcome that can lead to significant disability. The 
perioperative rate of death susceptibility in CSH pati-
ents is between 1.2 – 11%.7-8,12-13 
 The clinical features of these patients are highly 
variable, thus an initial misdiagnosis is a common 
dilemma. The complaints are often nonspecific, there-
fore a high level of suspicion must be maintained. The 
usual presenting complaints are altered mentation, 
unexplained history of focal weakness, seizures and 
symptoms of raised intracranial pressure like head-
ache, vomiting, etc. The variables that predispose for-
mation of chronic subdural hematoma are being male 
gender, age more than 70 years, cerebral atrophy, co-
agulopathies of various causes of chronic liver and 
renal diseases and use of anticoagulants for various 
concomitant diseases like ischemic heart disease 
(IHD). In elderly patients, the trauma and disprin the-
rapy can be risk factors in the development of a chro-
nic subdural hematoma. The CT and MRI scans are 
the common diagnostic investigations for CSH on 
which it appears as a pericerebral fluid collection 
along the convexities with a convex outer border and 
concave inner border. 
 
MATERIALS AND METHODS 
This study was conducted in the Department of Neuro-
surgery at Sheikh Zayed Hospital, Lahore from Jan-
uary 2014 to December 2017. We included all patients 
with chronic subdural hematoma with age between 
40 – 80 years who gave consent. We excluded preg-
nant women, children less than 18 years of age, pati-
ents with renal failure and those patients who did not 
give consent. Tumor surgery patients and trauma sur-
gery patients were also excluded from the study. We 
enrolled 48 older patients who were presented with 
chronic subdural hematoma (CSH). Informed consents 
were was taken from all patients or their attendants 
conformed to institutional ethical standards. Patients’ 
background information and clinical presentations 
were recorded. The history of any co-existing disease 
or co-morbidities such as hypertension, diabetes melli-
tus (DM), ischemic heart disease (IHD), chronic renal 
and liver diseases were recorded. The information on 
different drug intake, such as, anticoagulants, anti-
thrombolytic, chemotherapeutic agents, etc., was also 
noted along with corresponding duration of intake. 
Further, history regarding trauma was also noted. 
 Data analysis was performed in SPSS (v.22.0, 
IBM Corporation) software. A Chi Square (χ2) test was 
applied to look a relative significance at p < 0.050 in 
the co-morbidities (hypertension, DM, IHD, chronic 
kidney and liver diseases, trauma) between the respec-
tive occurrences out of total. A Chi Square (χ2) test 
was also applied to look a relative significance at 
p < 0.050 in the particular surgical option and outcome 
related parameters (GOS, recurrence, recovered, mor-
tality, postoperative complication) out of total. 
 All patients had undergone a CT scan (brain 
plain). The MRI procedure was also performed in most 
of the patients, especially in patients with isodense 
hematoma on CT. The routine lab tests were conduc-
ted for CBC, coagulation profile, PT, APTT, renal and 
liver profiles (LFTs, RFTs) and other relevant tests for 
the stabilization for surgical intervention. The regular 
mode of treatment for CSH was the burr-hole evacu-
ation i.e., copious irrigation with warm saline till the 
effluent was cleared. However, those patients which 
presented with recurrence or significant brain atrophy, 
the burr-hole evacuation was followed by drainage 
with a subdural drain for 48 to 72 hours. 
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RESULTS 
There were 48 patients with chronic subdural hema-
toma (CSH) enrolled in the Neurosurgery Department 
of Shaikh Zayed Hospital, Lahore. The mean age of 
male patients was 68 years and 56 years in female 
patients (Table 1). Out of 48 patients, 32 were male 
(66.6%) and 16 were females (33.33%). 
 
Table 1: Background Information of Chronic Sub-
dural Hematoma (CSH) Patients (n = 48). 
 
 
Male 
Patients 
Female 
Patients 
Number 32 16 
Percentage Prevalence % 66.6 33.3 
Mean Age (years) 68 56 
 
 Table 2 describes the clinical history in CSH 
patients. In majority of CSH patients, the trauma was 
not the cause of the diseases as history of trauma was 
present in only 11 (22.91%) CSH patients. Only two 
patients (4.16%) had chronic liver disease with altered 
LFTs and coagulation factors. However, 29 (60.41%) 
patients were on anticoagulants/antiplatelets for some 
other concomitant diseases such as IHD, stroke, etc. 
The 35 (72.91%) patients had hypertension, 30 
(62.5%) had diabetes mellitus and 29 (60.41%) pati-
ents had been treated for ischemic heart disease (IHD). 
History of chronic renal disease was present in only 
one (2.08%) patient. 
 Most of our patients (> 80%) did well with burr-
hole evacuation (unilateral/bilateral) with irrigation 
with normal saline under general anesthesia. Only few 
patients required treatment with burr-hole drainage 
with drain, whereas, the rest of the patients (> 80%) 
were treated only with burr-hole evacuation with irri-
gation. The 39patients (81.25%) recovered unevent-
fully and were discharged within a week’s time with 
(Glasgow Outcome Scale) GOS 5.Six (12.5%) patients 
required ICU management and remained admitted for 
more than two weeks. These patients were discharged 
with significant neurological deficit with GOS 2 – 3. 
Two patients (4.16%) were re-admitted because of 
recurrent chronic subdural hematoma. They were re-
explored and burr-hole evacuation with subdural drain 
placement was done. Moreover, two patients (4.16%) 
developed complications in the form of stroke during 
postoperative course. One patient (2.08%) died beca-
use of the pulmonary complications (aspiration pneu-
monia). Table 3 shows the summary of the manage-
ment of surgery and outcome of CSH patients. There 
 
 
 
Fig. 1:  Bilateral Subacute on Chronic Subdural Hematoma. 
 
 
 
Fig. 2):  MRI of Bilateral Chronic Subdural Hematoma. 
 
existed a relative significance (significant difference at 
p < 0.050) between all mentioned history parameters, 
surgery options and outcome (recurrence, recovered, 
mortality, postoperative complication) out of total 
except, diabetes mellitus, ischemic heart disease and 
anticoagulant therapies (Tables 2, 3). Some CT and 
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MRI scans are mentioned in figures. Figure 1 shows a 
bilateral subacute on CSH. Figure 2 represents an 
MRI of bilateral CSH. Figure 3 shows a CT scan of 
recurrent bilateral CSH. 
 
DISCUSSION 
The epidemiological study of CSH is still in progress 
around the world. The choice and option for CSH 
surgery is still in debate due to complexities of 
previous ailments in old age, non-specific symptoms 
and mistreatments.
1,3
 The purpose of the current study 
was to monitor effectiveness of the currently available 
surgical treatments to find out the resulting risk factors 
and outcomes of chronic subdural hematoma in elderly 
patients. Ko et al., (2008)
14
 reported following as risk 
factors of CSH: diabetes, epilepsy, dementia, use of 
antiplatelet or anticoagulants, chemotherapeutic drugs, 
bleeding occurrences, leukemia, liver dysfunction, 
kidney diseases and intracranial hypotension. Most of 
our patients recovered (81.25%; GOS 5) uneventfully, 
mostly treated with burr-hole evacuation with 
 
 
 
Fig. 3: CT Scan of Recurrent Bilateral Chronic Subdural 
Hematoma. 
Table 2:  Clinical History of Co-morbidities and Therapies in Chronic Subdural Hematoma (CSH) Patients. 
 
Clinical History 
Number of 
Cases 
Percentage 
Prevalence % 
p-value *df Chi square χ2 
Hypertension 35 72.91 0.001** 1 10.083 
Diabetes Mellitus 30 62.50 0.083 1 3.000 
Ischemic Heart Disease 29 60.41 0.149 1 2.083 
Chronic Renal Disease   2   4.16 0.000** 1 40.333 
Chronic Liver Disease   1   2.08 0.000** 1 44.083 
Trauma 11 22.91 0.000** 1 14.083 
Anticoagulants/Antiplatelets Therapy 29 60.41 0.149 1 2.083 
 
*degrees of freedom 
**significant (p < 0.05) 
 
Table 3:  Management of Surgery and Outcome. 
 
Parameters 
Number of 
Cases 
Percentage 
Prevalence % 
p-value *df 
Chi square 
χ2 
Type of Surgery 
Burr-hole evacuation 
with irrigation 
41 85.41 0.000** 1 24.083 
Burr-hole drainage with 
drain 
  7 14.58 0.000** 1 24.083 
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Glasgow Outcome 
Scale 
GOS: 5 39 81.25 0.000** 1 18.750 
GOS: 2 – 3   6 12.5 0.000** 1 27.000 
Recovered Uneventfully 39 81.25 0.000** 1 18.750 
CSH Recurrence   2 4.16 0.000** 1 40.333 
Postoperative Complication   2 4.16 0.000** 1 40.333 
Mortality   1 2.08 0.000** 1 44.083 
 
*degrees of freedom 
**significant (p < 0.05) 
 
irrigation. The 15% patients had required ICU mana-
gement with GOS 2 – 3. Older (> 65 years) male pati-
ents were more at risk of CSH. Trauma was not the 
only major cause of CSH, as history of trauma was not 
present in the majority (< 25%) of the patients. We 
found following significant risk factors, i.e., hyper-
tension (73%), DM (62.5%) and ischemic heart dise-
ase (60%) and intake of anticoagulant/antiplatelet dru-
gs (60%). A 4% recurrence was reported in our CSH 
patients. Stroke as complication was reported in two 
patients (4%) during postoperative course. And only 
one patient (2%) died of aspiration pneumonia. It has 
been reported that CSH was more present in men 
(98%) as compared to women (2%).
5
 This data is con-
sistent with other studies of different countries.
15-19
 In 
our cases, there were more male patients (65.6%) as 
compared to female patients. Balser et al., (2015)
5
 
reported that 73% of CSH patients were with age gre-
ater than 65 years in their study. This data is consistent 
with other studies of different countries.
20-21,18
 
 Yamamoto et al., (2003)
22
 described that seizure 
history and previous diabetes mellitus are closely 
associated with the incidence of CSH recurrence. 
Adhiyaman et al., (2001)
23
 indicated that CSH can 
follow a minor trauma, but a history of direct trauma 
to the head was absent in around half of the presented 
cases. They also reported that use of anticoagulant 
therapies as significant risk factors in the occurrence 
of CSH.
2
 Pneumonia has been reported as the medical 
complexity in about some of CSH cases.
2,24-26
 Stroke 
as complication was reported in our two patients (4%) 
during postoperative course. It is well accepted that 
postoperative complications and recurrences exist in 
CSH.
27
 The medical history, such as hypertension, 
diabetes mellitus, COPD, dementia and ischemic heart 
diseases have been reported in patients with chronic 
subdural hematoma.
28
 Bleeding tendency and hema-
toma density have been considered as major risk fac-
tors of CSH recurrences.
14
 It is known that anticoagu-
lation and antiplatelet medications can increase the 
risk of hemorrhages.
5
 It is mentioned by Balser et al., 
(2015)
5
 that a subdural hematoma can be prevented 
spontaneously if it is diagnosed timely and managed 
properly, however, an untreated or misdiagnosed hem-
atoma can be fatal in the form of impaired neurolo-
gical condition or cerebral decompensation.
29
 More-
over, a recurrence rate would be less than 15% of CSH 
patients treated with drainage as compared to those 
who do not.
30
 Yang et al., (2012)
31
 mentioned that old 
age susceptibility has been anticipated from an increa-
sed cerebral atrophy, because a positive correlation 
exists between the prevalence of CSH and the quantity 
of brain atrophy. Such increased atrophy can prompt 
trauma which promotes a spacing in the layer of dura-
arachnoid,
32
 because granulation tissue proliferation 
can be induced by fibrin on inner side of dural sur-
face.
33
 
 In the current study, 60% of CSH patients were 
having anticoagulants or aspirin for some other prob-
lem which is consistent with other studies. An increa-
sed use of anticoagulant drugs in elderly patients with 
brain atrophy conditions can significantly raise the 
CSH incidence. The use of antiplatelet or anticoagu-
lant drugs can increase the risk of CSH condition up to 
10 folds.
34
 The elevated prevalence of CSH in the aged 
population emphasizes the fact that CSH could likely 
to emerge from degenerative disease other than trau-
ma. We also found that trauma was not the major cau-
se of CSH, as history of trauma was not present in the 
majority of the patients. In the past, the pathogenesis 
of CSH was never been considered a consequence of 
traumatic condition alone.
35-36
 It was first demonstra-
ted in the 18
th
 century by Virchow that: ―exudates ga-
ther in subdural gaps from inflammatory processes‖.35 
Later on, in the beginning of the 19
th
 century, Trotter 
suggested trauma in contrary to the inflammatory 
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processes.
4
 Further studies have explained that the 
presence of blood in the subdural space, secondary to 
meningeal trauma prompts some inflammatory pro-
cesses by dural cells, which can lead to the develop-
ment of vascular neomembrane and cause recurrent 
microhemorrhages followed by hematoma growth.
37-
38,35
 A study by Sousa et al., (2013)
18
 has also reported 
that less than 50% of patients did not present a trauma 
history.
18
 Moreover, a study demonstrated that CSH 
was reported nine months later, after trauma inci-
dence.
39
 It is known that a trauma emerges from the 
exudation of blood in subdural space and a large 
subdural space can predispose to blood collection. 
Bridging veins of subdural region include thin vessel 
walls with reduced collagen and hence results in more 
susceptibility than the subarachnoid region.
40
 
 The surgical evacuation procedures via burr-holes 
is accepted globally but percentage outcome varies up 
to 40% [1 Ernestus et al., 1997]. Most of our patients 
did well with burr-hole evacuation (unilateral/bilateral) 
with irrigation with normal saline under general anes-
thesia. Only few patients required treatment with burr-
hole drainage with drain. Ernestus et al., (1997)
1
 con-
ducted a retrospective study to find out operative opt-
ions in patients with CSH and suggested that burr-hole 
craniostomy with closed-system drainage is best choi-
ce for CSH treatment.
1
 Lee et al., (2004)
41
 supported 
burr-hole drainage with irrigation of hematoma and 
closed-system drainage. Mori and Maeda (2001)
27
 
reported a good recovery in 500 consecutive CSH 
patients who were treated with burr-hole craniostomy 
with closed system drainage. In their study, around 1% 
patients died due to disseminated intravascular coagu-
lation. They found recurrence in about 10% of CSH 
patients. Existence of cerebral infarction and old age 
were significantly correlated with poor brain re-expan-
sion. They found postoperative complications in aro-
und 5% of CSH patients such as acute subdural hema-
toma from an incomplete hemostasis of wound on the 
scalp and tension pneumocephalus.
27
 During 1943 – 
1980, the CSH patients were treated with burr-hole 
without drainage as mentioned by Robinson (1984) 
and mortality rate of 1.5% was reported.  Moreover, a 
recent comprehensive systemic review mentioned that 
a use of closed system drainage after burr-hole evacu-
ation can have a more potential to eliminate recur-
rences and general complications.
42
 We reported a 4% 
recurrence in our CSH patients. In chronic subdural 
hematoma, a recurrence is likely to occur and Tori-
hashi et al., (2008)
43
 conducted a study to determine 
independent predictors linked with CSH recurrence in 
surgical cases. They considered following factors: age, 
sex, DM, hypertension, cerebrovascular disease, heart 
disease, anticoagulant & antiplatelet treatments, bila-
teral CSH and atrial fibrillation. They reported recur-
rence in 61% patients. They suggested bilateral chro-
nic subdural hematoma as an independent predictor for 
CSH recurrence. They also concluded that medications 
like anticoagulants and antiplatelets might provoke the 
development of CSH as the association was found 
insignificant.
43
 Ko et al., (2008)
14
 mentioned that in 
their institute, the burr-hole drainage with drain has 
been an effective treatment option from 20 years. 
Similarly, Oishi et al., (2001)
44
 also supported the use 
of burr-hole surgical option. 
 A retrospective CSH study during 1980 – 2002 
was conducted by Gelabert-González et al., (2005)
2
 
and included patients treated with burr-hole cranio-
tomy with closed-system drainage. They observed 
around 17% postoperative complications and 2% mor-
tality rate. Patient age greater than 70 and clinical 
grade, both are related to poor prognosis.
2
 However, 
Singla et al., (2013)
3
 explained that a subdural evacu-
ating port system SEPS is an effective and safer with 
low invasiveness treatment option to manage CSH. 
Weigel et al., (2003)
45
 conducted research to find out 
survival rates in patients of 90 years of age with symp-
tomatic CSH. It was mentioned that a postoperative 
outcome of CSH has not yet improved from last 20 
years. It was also mentioned that twist-drill and burr-
hole craniostomy are first or primary treatment level, 
whereas, craniotomy can be considered as second tre-
atment level.
45
 The CT is a diagnostic tool in great 
majority of chronic subdural hematoma. However, in 
an isodense hematoma with marked cerebral atrophy 
and prominent subarachnoid spaces may present diffi-
culties to establish diagnosis. Magnetic resonance ima-
ging (MRI) will be unequivocally helpful in confirm-
ing the diagnosis. In these patients coagulation abnor-
malities are frequently associated and their periope-
rative management is important. In most of symp-
tomatic patients, an evacuation can be carried out 
under local or general anesthesia with simple burr 
holes (unilateral or bilateral) followed by serial CT 
scans in postoperative management. An early diagno-
sis and evacuation were well rewarding in majority of 
the patients, as more than 80 percent of our patients 
improved markedly without any neurological deficit. 
 
CONCLUSION AND RECOMMENDATION 
Chronic Subdural hematoma (CSH) can be effectively
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treated by relatively simple surgical intervention if 
diagnosed early and morbidity & mortality can signi-
ficantly be reduced. We found burr-hole evacuation 
(unilateral/bilateral) with irrigation as an effective 
treatment against CSH as most of the patients (>80%) 
were recovered with it. In majority of CSH patients, 
the trauma was not the only cause of the diseases as 
history of trauma was not present in the majority of the 
patients. Therefore, some other synergistic risk factors 
may also involve in CSH formation in old age. The 
significant risk factors were: hypertension (73%), DM 
(62.5%) and ischemic heart disease (60.41%) and 
intake of anticoagulant/ antiplatelet drugs (60%). 
Recurrent CSH was reported 4%, postoperative 
complications were 4% and mortality was 2%. Further 
studies are required to affirm other risk factors. 
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